ReviewEmerging infectious diseases2024
Reemergence of Oropouche Virus in the Americas and Risk for Spread in the United States and Its Territories, 2024.
Review in Emerging infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Oropouche virus infection: clinical spectrum, geographic expansion, and emerging maternal-fetal implications.Infection · 2026Review
- Low Generation Culex quinquefasciatus from Texas and Culex pipiens from New Jersey Are Incompetent Vectors for Oropouche Virus.The American journal of tropical medicine and hygiene · 2026Article
- Emergence and endemicity of arboviruses in Haiti: a review.IJID regions · 2026Review
- Review
- Phylogeographic dynamics of oropouche virus in the Colombian Amazon: Evolutionary insights in a climatic context.PLoS neglected tropical diseases · 2026Article
- Estimated suitability distribution for Culicoides (Haematomyidium) paraensis (Diptera: Ceratopogonidae) in the contiguous United States and associated Caribbean territories.Journal of medical entomology · 2026Article
- Review
- Viral, Clinical, and Epidemiological Characteristics of Oropouche Fever in Southeastern Brazil.Open forum infectious diseases · 2026Article
- Screening for Oropouche virus in wild bird samples collected from wildlife rehabilitation centers, Florida, United States, 2021-2024.Frontiers in public health · 2026Article
- Risk Assessment of Oropouche Virus Transmission by Mosquitoes in Europe.The Journal of infectious diseases · 2025Article
- Mapping evolutionary paradigm of Oropouche virus driven by dinucleotide bias and context-dependent codon bias.Virulence · 2025Article
- The Importance of Public Health and Clinical Context in Investigating and Responding to Cases of Oropouche Virus Disease.Open forum infectious diseases · 2025Article
- Structure-Based Identification of Natural Inhibitors Targeting the Gc Glycoprotein of Oropouche Virus: An In Silico Approach.International journal of molecular sciences · 2025Article
- Phylogenomics and structural modelling feature accelerated evolution of Oropouche virus: 1955 to 2024.Virologica Sinica · 2025Article
- Oropouche virus efficiently replicates and is immunostimulatory in vivo in nonhuman primate species.Science advances · 2025Article
- First Case of Neuroinvasive Oropouche Virus in Wisconsin: A Case Report.Open forum infectious diseases · 2025Article
- Oropouche Virus: The Silent Threat of a Re-emerging Arbovirus.Archives of Razi Institute · 2025Review
- Estimation of Incubation Period for Oropouche Virus Disease among Travel-Associated Cases, 2024-2025.Emerging infectious diseases · 2025Article
- The Role of Hematophagous Arthropods, Other than Mosquitoes and Ticks, in Arbovirus Transmission.Viruses · 2025Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oropouche virus has recently caused outbreaks in South America and the Caribbean, expanding into areas to which the virus was previously not endemic. This geographic range expansion, in conjunction with the identification of vertical transmission and reports of deaths, has raised concerns about the broader threat this virus represents to the Americas. We review information on Oropouche virus, factors influencing its spread, transmission risk in the United States, and current status of public health response tools. On the basis of available data, the risk for sustained local transmission in the continental United States is considered low because of differences in vector ecology and in human-vector interactions when compared with Oropouche virus-endemic areas. However, more information is needed about the drivers for the current outbreak to clarify the risk for further expansion of this virus. Timely detection and control of this emerging pathogen should be prioritized to mitigate disease burden and stop its spread.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.